Search - tctmd.com

Displaying 461 - 480 of 1545

Sort: Relevancy | Date

Presentation TCT 2014

Bleeding events are reduced and survival improved by use of radial access during primary percutaneous coronary intervention for patients receiving glycoprotein inhibitors

Presenter: Adam Brown

September 16, 2014

Presentation TCT 2014

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

Preventive versus Culprit Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta Analysis

Presenter: Yeo-Jeong Song

September 16, 2014

Presentation TCT 2014

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Presenter: Milan Chag

September 16, 2014

Presentation TCT 2014

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

Heparins Crossover In Percutaneous Coronary Interventions: Is It A Real Issue With Increasing Rate Of Transradial Procedures?

Presenter: Stefano Rigattieri

September 16, 2014

News Conference News TCT 2014

Views Differ on Future of Percutaneous Mitral Valve Therapies

September 16, 2014

News Industry News

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

September 16, 2014

News Industry News

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

September 16, 2014

Presentation TCT 2014

TCT 12: The Impact of Platelet Receptor Gene Polymorphisms on Clinical Outcomes in Patients with ST-Elevation Myocardial Infarction After Percutaneous Coronary Intervention

Presenter: Ori Ben-Yehuda, Matthew T. Roe, David J. Moliterno, Jia-Hui Zhang

September 15, 2014

Presentation TCT 2014

TCT 460: Bivalirudin Versus Heparin During Percutaneous Coronary Intervention: A Meta-analysis of Randomized Trials

Presenter: John A. Bittl, Tullio Palmerini, Salvatore Cassese, MD

September 15, 2014

Presentation TCT 2014

TCT 86: Quantification and Impact of the Proportion of Coronary Disease Burden Treated by Percutaneous Coronary Intervention: The SYNTAX Revascularization Index

Presenter: David P. Faxon, Philippe Généreux

September 15, 2014

Presentation TCT 2014

VELOCITY: A Prospective, Randomized Trial of Peritoneal Hypothermia in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Presenter: Stefan K. James, Cindy L. Grines, Gregg W. Stone

September 15, 2014

Presentation TCT 2014

TCT 102: Incidence of Angina and Chest Pain Following Percutaneous Coronary Intervention: A Retrospective Analysis Using Administrative Claims Data in the United States

Presenter: David P. Faxon, Ori Ben-Yehuda

September 15, 2014

Presentation TCT 2014

TRANSLATE-ACS: A Large-Scale Registry Comparing Patterns of Use and One-Year Outcomes with Prasugrel Versus Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Presenter: Stefan K. James, Cindy L. Grines, Tracy Y. Wang

September 15, 2014

News Industry News

St. Jude Medical Announces Launch of OPTIS Integrated System

September 15, 2014

News Industry News

New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients

September 15, 2014

News Industry News

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

September 15, 2014

News Industry News

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

September 15, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

Advertisement

Bleeding events are reduced and survival improved by use of radial access during primary percutaneous coronary intervention for patients receiving glycoprotein inhibitors

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Preventive versus Culprit Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta Analysis

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Heparins Crossover In Percutaneous Coronary Interventions: Is It A Real Issue With Increasing Rate Of Transradial Procedures?

Views Differ on Future of Percutaneous Mitral Valve Therapies

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

TCT 12: The Impact of Platelet Receptor Gene Polymorphisms on Clinical Outcomes in Patients with ST-Elevation Myocardial Infarction After Percutaneous Coronary Intervention

TCT 460: Bivalirudin Versus Heparin During Percutaneous Coronary Intervention: A Meta-analysis of Randomized Trials

TCT 86: Quantification and Impact of the Proportion of Coronary Disease Burden Treated by Percutaneous Coronary Intervention: The SYNTAX Revascularization Index

VELOCITY: A Prospective, Randomized Trial of Peritoneal Hypothermia in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

TCT 102: Incidence of Angina and Chest Pain Following Percutaneous Coronary Intervention: A Retrospective Analysis Using Administrative Claims Data in the United States

TRANSLATE-ACS: A Large-Scale Registry Comparing Patterns of Use and One-Year Outcomes with Prasugrel Versus Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

St. Jude Medical Announces Launch of OPTIS Integrated System

New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content